Xiangyu Medical Co. Ltd. A - Asset Resilience Ratio
Xiangyu Medical Co. Ltd. A (688626) has an Asset Resilience Ratio of 1.53% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Xiangyu Medical Co. Ltd. A working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2023)
This chart shows how Xiangyu Medical Co. Ltd. A's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Xiangyu Medical Co. Ltd. A balance sheet assets.
Liquid Assets Composition Over Time
This chart breaks down Xiangyu Medical Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 688626 current and long-term liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥50.18 Million | 1.53% |
| Total Liquid Assets | CN¥50.18 Million | 1.53% |
Asset Resilience Insights
- Limited Liquidity: Xiangyu Medical Co. Ltd. A maintains only 1.53% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Xiangyu Medical Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Xiangyu Medical Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
|
Profound Medical Corp
TO:PRN |
Medical Devices | 67.66% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
Epitomee Medical Ltd
TA:EPIT |
Medical Devices | 0.24% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
Annual Asset Resilience Ratio for Xiangyu Medical Co. Ltd. A (2021–2023)
The table below shows the annual Asset Resilience Ratio data for Xiangyu Medical Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 6.26% | CN¥162.19 Million ≈ $23.73 Million |
CN¥2.59 Billion ≈ $379.31 Million |
-20.62pp |
| 2022-12-31 | 26.88% | CN¥636.47 Million ≈ $93.14 Million |
CN¥2.37 Billion ≈ $346.52 Million |
-2.82pp |
| 2021-12-31 | 29.70% | CN¥648.14 Million ≈ $94.84 Million |
CN¥2.18 Billion ≈ $319.38 Million |
-- |
About Xiangyu Medical Co. Ltd. A
Xiangyu Medical Co.,Ltd engages in the research and development, manufacture, and marketing of rehabilitation and physiotherapy equipment in China. It provides various therapy such as smart occupational, electro, sport, rehab, cold and heat, gait training device, hydrotherapy, air compression, phototherapy, traction table, magnetic, CPM, occupational, shock wave and ultrasound, massage, treatment… Read more